325
COMPARISON EFFICACY AND SAFETY BETWEEN ATEZOLIZUMAB PLUS BEVACIZUMAB AND LENVATINIB AS FIRST-LINE SYSTEMIC THERAPY FOR HEPATOCELLULAR CARCINOMA: A REAL-WORLD STUDY
Date
May 19, 2024
Tracks
Related Products
ABBREVIATED MAGNETIC RESOSNANCE IMAGING IS A COST-EFFECTIVE STRATEGY FOR HEPATOCELLULAR CARCINOMA SURVEILLANCE IN CIRRHOSIS
BACKGROUND AND AIMS: Screening tools are needed for early detection of NAFLD-fibrosis. We aimed to identify risk factors for NAFLD-fibrosis in the multiethnic population of the U.S. and thus accelerate development of equitable screening tools…
NEUTROPHIL-TO-LYMPHOCYTE RATIO TO PREDICT THE SHORT-TERM PROGNOSIS IN PATIENTS WITH ACUTE LIVER DECOMPENSATION OR ACUTE-ON-CHRONIC LIVER FAILURE: A MULTICENTER STUDY
BACKGROUND: Due to development of an immune dysregulated phenotype, advanced liver disease in all its forms predisposes to sepsis acquisition and related mortality…
Portal Hypertension, Complications of Cirrhosis, and GI Bleeding
DEVELOPMENT AND VALIDATION OF THE HOPE-EVL SCORE: A SCORING SYSTEM FOR IN-HOSPITAL MORTALITY FOLLOWING BAND LIGATION IN ESOPHAGEAL VARICEAL BLEEDING
COMBINATION OF MODIFIED ALBUMIN-BILIRUBIN GRADE AND PLATELET COUNT TO PREDICT VARICES IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
Variceal bleeding in hepatocellular carcinoma (HCC) patients is related to a poor prognosis. Therefore, identifying high-risk varices (HRV) in HCC patients is crucial. Unlike in cirrhosis, where Baveno VII uses non-invasive tests to rule out HRV, this approach doesn't extend to HCC…